Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : $1B Mkt -(BUGS) Bio- Remediation of Polluted Soils -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (12)	1/31/1998 11:57:00 PM
From: Frank Buck	Respond to of 54

Cisco, The existing management has just recently (July 17, '97) taken over this pre-existing publicly traded company called Global Venture Funding <GVF> New management headed by Robert Brehm/CEO has changed the direction of the previous company to what you probably have read in the opening screen. The BOD authorized a one for twenty reverse split late August of '97. (The previous management and direction of the company was in prepaid cellular communications and the stock evidently was in the cheap, cheap range. They recently announced a total divestment of the ties with any of the cellular (old) business. Anyway the total thrust of this new management is in environmental remediation. They acquired XyclonyX, (in late summer '97) for 250,000 shares of common. XyclonyX is a California HQ'd microbial technology company powerhouse. XyclonyX (I hate typing that word) has been in business privately for thirty-years and has existing licensed products that have been in mainstream usage. They have seven product line areas targetted at nine major market areas. In '98 (Global Venture Funding) GVF will create West Coast Fermentation Center which will provide large scale microbial cultures to be sold to outside licensees and other subsidiaries of GVF. As recent as Nov. of '97 GVF formed and wholly owns Sub-Surface Waste Management which is the manufacturing and selling arm of GVF. They will build and sell a (patented) system called Bio-Raptor...which is technology licensed from XyclonyX. The existing shares outstanding is around 1.44M and the float is currently at the 300K range. The Company plans to become an environmental technology conglomerate. They are aggresively seeking to obtain small cap listing in '98. That requires a substantial increase in the present $1.5-62 range. They also need $15M to implement their strategy which requires; clean rooms (for the microbes, that is an oxymoron isn't it) lab, other production space and storage space for the raw material and finished material. Their fiscal year ended Sept 30, '97 and the annual should be available. They have all the EDGAR parameters in place to file electronically. They are doing this in expectation of the small-cap requirements. Since they are essentially a new Company under an old formed "shell" they did not have the benefit of an IPO and an equity capital infusion. Capital infusion is scheduled in fiscal '98. Brehm had stated in August: << I don't expect to show a profit for the September 30 fiscal year, but do intend to have the audit out on schedule and a new management team in place shortly thereafter.">> Projections for profitability are $1 by 9/98 and $2 by '99 - that is more than the current share price. Any increases in the common used to finance expansion and further acquisitions should take the increases into consideration. gvfcellular.com The "Bug Lady" Dr. Mery Robinson (who heads the XyclonyX division) is the daughter of the the late George M. Robinson, who had the distinction of being the first man to use microbial clean-up on a full scale basis on an oil spill in 1968. The Company GVF realizes that licensing their proprietary technology to major players in the petroleum production market and and the environmental remediation market is important. Additional market segments that their product lines are capable of being licensed to or products sold to are; Commercial Retail, commercial wholesale, industrial, municipal, agricultural, mfging, military, healthcare, and energy sectors. << If they plan to net $2 million in 1998, they have to start making money in a hurry!>> With a fiscal ending in Sept. '98 your not kidding. Hope this answers some of your questions. The stock price has been going up on low volume. That is a good sign!! Sellers (maybe) from the old regime are finished liquidating their shares. Thanks for the inquiry! Frank

To: Cisco who wrote (12)	2/1/1998 12:23:00 AM
From: Frank Buck	Read Replies (1) \| Respond to of 54

Cisco, Pro Forma Financial Estimates Fiscal Year 9/97 (est) 9/98 9/99 Revenue $55K $10 MM $60 MM Income -$400K $2 MM $12.0M # Common 1.3 MM 2 MM 6 MM EPS(est) $(.30) $1.00 $2.00 Along with the tripling in shares outstanding they anticipate a sixfold increase in revenues and income and a doubling of EPS from '98 to '99. The newswires will/should tell us how they are doing. Frank

To: Cisco who wrote (12)	2/4/1998 3:41:00 PM
From: Frank Buck	Read Replies (1) \| Respond to of 54

Cisco, GVF (BUGS) just released an appointment of two internationally recognized biotechnology experts to the Technical Advisory Board of Xyclonyx- one of their wholly owned subs. One of the experts has testified as an expert witness before Congress, the other is a world class industry expert on large-scale industrial fermentation microbiology. biz.yahoo.com Looks like two great appointments. They certainly have the expertise. Now lets see if they can start getting some contracts signed. Maybe Peter Gombrich should make himself available.<g> Frank